首页 | 本学科首页   官方微博 | 高级检索  
     

增殖细胞核抗原表达在晚期卵巢上皮癌化疗效果中的预测价值
引用本文:银铎,李秀琴,陆景明. 增殖细胞核抗原表达在晚期卵巢上皮癌化疗效果中的预测价值[J]. 癌症, 2001, 20(2): 195-196
作者姓名:银铎  李秀琴  陆景明
作者单位:中国医科大学第二临床学院妇产科,
摘    要:目的:研究晚期卵巢上皮癌增殖细胞核抗原(proliferatingcellnuclearantigenPCNA的表达与化疗效果的关系。方法:选择28例Ⅲ/Ⅳ期上皮性卵巢癌手术后继续行6个疗程以上化疗有效者及28例与之相匹配的化疗无效者手术时的卵巢癌标本,以免疫组化SP法检测PCNA的表达。结果化疗无效组与化疗有效组PCNA表达强度分别为32.14±19.27%23.18±16.38%,差异显著P<0.05。结论:PCNA在化疗反应不同的上皮性卵巢癌中表达不同,有可能成为卵巢癌化疗效果的预测指标。

关 键 词:卵巢上皮癌 药物治疗 增殖细胞核抗原
文章编号:1000-467X(2001)02-0195-02
修稿时间:2000-05-29

Value of PCNA Expression in Predicting Advanced Epithelial Ovarian Cancer Chemotherapy Efficiency
YIN Duo,LI Xiu-qin,LU Jing-ming. Value of PCNA Expression in Predicting Advanced Epithelial Ovarian Cancer Chemotherapy Efficiency[J]. Chinese journal of cancer, 2001, 20(2): 195-196
Authors:YIN Duo  LI Xiu-qin  LU Jing-ming
Affiliation:YIN Duo,LI Xiu-qin *,LU Jing-ming The Second Clinical College,China Medical University,Shenyang 110003,P.R.China
Abstract:Objective: The current study was designed to investigate the relationship between the proliferating cell nuclear antigen(PCNA) expression and the effect of chemotherapy in the patients with advanced epithelial ovarian cancer. Methods: The samples were selected at epithelial ovarian cancer Stage Ⅲ /Ⅳ , who received more than 6 courses of postoperational chemotherapy, and showed effective (chemotherapy-effective group,28 cases). Immunohistochemical SP method was used to detect the expression of PCNA protein. Result: The expressions of PCNA in chemotherapy-effective and chemotherapy-ineffective were 32.14± 19.27% ,23.18± 16.38% (P<0.05), respectively. Conclusion: The expression of PCNA were different in epithelial ovarian cancer with different response to chemotherapy, and it may serve as a predicting factor of chemotherapy efficiency in epithelial ovarian cancer.
Keywords:Proliferating cell nuclear antigen  Ovarian neoplasms  Chemotherapy e fficiency
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号